Related Experiment Videos
[Should men aged 20 to 30 years with hypercholesterolemia be managed in the same way as older men?]
F Delahaye1, J Emmerich, E Bruckert
1Hôpital cardiologique, BP Lyon Montchat.
Insights
Extrapolating cholesterol intervention data to young men is justified. Treating hypercholesterolemia in young men is crucial due to longer exposure to cardiovascular risks.
Area of Science:
- Cardiovascular Medicine
- Preventive Cardiology
Context:
- Most serum cholesterol intervention studies focus on middle-aged men.
- Atherosclerosis, a progressive disease, affects individuals throughout their lifespan.
- Elevated serum cholesterol is a known risk factor for coronary heart disease.
Purpose:
- To evaluate the justification of extrapolating cholesterol intervention trial results from middle-aged men to younger men (20-30 years old).
- To assess the potential benefits of medical intervention for hypercholesterolemia in young men.
Summary:
- Serum cholesterol levels increase with age, peaking around 60.
- While lifelong dietary changes for a 6.7% cholesterol reduction may yield only 4 months' life expectancy gain in 20-year-olds, a 20% reduction offers 12 months.
- There is no scientific basis to withhold treatment recommendations for young adults based on data from older populations.
Impact:
- Young men face longer cumulative exposure to cardiovascular risks, necessitating serious consideration of hypercholesterolemia treatment.
- Early intervention in young men can mitigate long-term coronary risk.
- Findings support the proactive management of high cholesterol in younger demographics.
Abstract:
Serum cholesterol intervention studies have been mainly performed in middle-aged men. Is the extrapolation of these results to men aged 20 to 30 years justified? Atherosclerosis is a process which continues throughout life. It is clear that increased serum cholesterol levels are associated with a higher coronary risk. In addition, serum cholesterol levels increase with age up to 60 years old. Do young men obtain the same benefits from medical intervention as older men? Therapeutic trials have been performed in middle-aged men. The increase in life expectancy associated with a 6.7% lowering of the serum cholesterol by life-long dietary restrictions would only be 4 months in 20 year old subjects at high risk (hypertension, smokers, low HDL cholesterol). With a 20% reduction in serum cholesterol, the gain would be 12 months. There is no reason for not extrapolating acquired data in the over 30s to 20 to 30 year old subjects. Due to the fact that young subjects are exposed to the risk for longer periods, it is advisable to treat their hypercholesterolaemia even more seriously than that of older patients.